Proteinuria Clinical Trials
137 clinical trials for Proteinuria across international registries, including 13 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy — RECRUITING · PHASE2
- Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria — RECRUITING · PHASE1
- Improving Renal Complications in Adolescents With Type 2 Diabetes Through REsearch Cohort Study (National iCARE Study) — RECRUITING
- A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria — RECRUITING · PHASE3
- A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria — RECRUITING · PHASE3
- A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines — RECRUITING · NA
- Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) — RECRUITING
- Proteinuria in Pre and Post Transplant — RECRUITING
- Nefecon and Ambrisentan in IgA Nephropathy — RECRUITING · PHASE4
- Beneficial Effect of Amiloride on Progression of Chronic Kidney Disease — RECRUITING · PHASE2
- Effects of Exogenous Ketosis on Proteinuria and Renal Function — RECRUITING · NA
- EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV — RECRUITING
- ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank — RECRUITING
- Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis — ACTIVE_NOT_RECRUITING · PHASE4
- Proteinuria in Normotensive Diabetic Patients: ARBs Alone or in Combination of SGLT2i — ACTIVE_NOT_RECRUITING · PHASE2
- Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria — NOT_YET_RECRUITING · NA
- Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients — NOT_YET_RECRUITING · PHASE4
- Huaier Granule and Proteinuria — NOT_YET_RECRUITING · PHASE2
- CHART-C3G/CLNP023B12011 — NOT_YET_RECRUITING
- KPs Supplement for Inflammation, Oxidative Stress and Lipid Abnormalities in CKD Patients. — COMPLETED · NA
- Outcome of Use of a Novel Modulator of Oxidative Phosphorylation on Kidney Function in Patients With Progressive Chronic Kidney Disease — COMPLETED
- Sitaxsentan in Proteinuric Chronic Kidney Disease — COMPLETED · PHASE2
- Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study — NOT_YET_RECRUITING
- Effects of Traditional Chinese Medicine (GSJYF) in Children With Inherited Proteinuric Kidney Disease — COMPLETED · NA
- Efficacy of On-venous Laser Irradiation of Blood on Diabetes Kidney Disease Patients — OTHER · NA
- Does the Presence of Preoperative Proteinuria Predict Postoperative Acute Kidney Injury in Obese Patients Undergoing Elective Laparoscopic Surgery? — COMPLETED
- Comparison of the Role of Losartan Alone vs Hydrochlorothiazide Plus Losartan — OTHER · NA
- Maternal Treatment With ACE-inhibitors and Breastfeeding: a Mono-centric Study on the Exposure Through Breast Milk — COMPLETED · NA
- Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria — COMPLETED · PHASE2
- Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy — COMPLETED
- An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2)) — COMPLETED · PHASE3
- Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin. — COMPLETED · PHASE4
- Preventing Sickle Cell Kidney Disease — TERMINATED · PHASE2
- Postoperative New-onset Proteinuria and Adverse Outcomes. — COMPLETED
- Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney Disease — COMPLETED
- Effect of Low Salt and Ckd Progression — COMPLETED · NA
- The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease — COMPLETED · PHASE3
- An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and Proteinuria — COMPLETED
- Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria — COMPLETED · PHASE1
- Azilsartan in Patients With Diabetic Kidney Disease and Hypertension — OTHER · NA
- Belatacept Conversion in Proteinuric Kidney Transplant Recipients — COMPLETED · PHASE2
- Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induced Kidney Injury — TERMINATED · PHASE2
- Efficacy and Safety of Dapagliflozin in Children With Proteinuria — COMPLETED · PHASE4
- Effects of Whole Food, Plant-Based Nutrition on Chronic Kidney Disease With Proteinuria — TERMINATED · NA
- Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease — OTHER · PHASE2
- Empagliflozin in Patients With Glomerulonephritis — COMPLETED · PHASE3
- Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers — COMPLETED
- Effects of Nitrate-rich Beetroot Juice in Pregnant Women With High Blood Pressure — OTHER · NA
- The Effect of COVID-19 Pandemia on Follow up of Patients With Chronic Kidney Disease — COMPLETED
- Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease — WITHDRAWN · PHASE4
Refine this search